Shares of Core Scientific, Inc. (CORZ) plummeted 5.15% in premarket trading on Tuesday, reflecting a sharp negative reaction from investors.
The decline follows the company's announcement that it plans to monetize substantially all of its remaining Bitcoin holdings in 2026 to fund liquidity needs and its pivot toward AI infrastructure. Additionally, the company reported disappointing fourth-quarter results, with adjusted earnings per share of $(0.29) missing the $(0.18) estimate and sales of $79.763 million falling short of the $105.711 million expectation.
Adding to the negative sentiment, multiple analysts lowered their price targets on Core Scientific's stock. Clear Street reduced its target to $25 from $27, Cantor Fitzgerald cut its target to $25 from $26, and Ladenburg lowered its target to $23.75 from $24.50, all while maintaining positive ratings on the shares.
Comments